摘要
背景:世界范围内糖尿病发病率的上升促使研究人员从天然产品中探索新的抗糖尿病药物。关于糖尿病的伦理领域研究已经在全球扩展,记录了大量抗糖尿病的民间药用植物。尽管如此,迄今为止还没有对这些调查进行过系统的审查。这项研究记录了全球传统上用于管理糖尿病的药用植物。 方法:对科学直接、医学mebmed和谷歌学者等关键数据库进行了研究。植物列表和国际植物名称索引(IPNI)被用于验证科学的植物名称。 结果:2004年92个国家报告了1112属197科。主要报道豆科(105属193种)、菊科(97属188种)和羊科科(47属121种)。龙骨,龙骨,青葱属。法官。,金甘草(L.)。R.Br。前Sm.、芦荟(L.)Burm.f.和葱属植物的报道最多。事实上,实验研究已经证明了它们的抗糖尿病特性。几种通过不同机制作用的抗糖尿病化合物,包括莫莫苷、香霉苷、卡拉苷、葫芦素、香霉苷、香豆苷、s-烯丙基半胱氨酸亚砜 A. 讽刺,柠檬类从 A. 籼稻、生物碱包括长春碱、长春碱、长春碱和长春碱 C. 玫瑰酸、油苷和橙酸酸、黄酮c苷、异裂苷、裸子苷、裸子苷和妊娠糖苷 A. 维拉,和槲皮素来自 A. 有权杖。 结论:本文综述首次提供了世界范围内用来抗糖尿病的传统药用植物的汇编清单。
关键词: 糖尿病,民族医学、植物,传统医学,民族植物学、传统药用植物、c-糖苷、裸子植物苷类。
Current Medicinal Chemistry
Title:Ethnomedicinal Plants for the Management of Diabetes Worldwide: A Systematic Review
Volume: 28 Issue: 23
关键词: 糖尿病,民族医学、植物,传统医学,民族植物学、传统药用植物、c-糖苷、裸子植物苷类。
摘要:
Background: The increasing incidence of diabetes worldwide has urged researchers to explore novel antidiabetic agents from natural products. Ethnomedicinal field studies on diabetes have expanded across the globe, documenting large numbers of folk medicinal plants against diabetes. Nonetheless, a systematic review of these surveys has not been conducted so far. This study documents the medicinal plants traditionally used globally for managing diabetes.
Methods: Key databases including Sciencedirect, Medline/PubMed, and Google Scholar were scrutinized. The Plant List and The International Plant Names Index (IPNI) were used to validate the scientific plant names.
Results: 2004 traditionally used plants belonging to 1112 genera and 197 families were reported across 92 countries for the management of diabetes. Leguminosae (105 genera and 193 species), Compositae (97 genera and 188 species), and Lamiaceae (47 genera and 121 species) were the main plant families reported. Momordica charantia L., Syzygium cumini (L.) Skeels, Allium sativum L., Azadirachta indica A.Juss., Catharanthus roseus (L.) G.Don, Olea europaea L., Trigonella foenum-graecum L., Gymnema sylvestre (Retz.) R.Br. ex Sm., Aloe vera (L.) Burm.f., and Allium cepa L were the species mostly reported. Indeed, the antidiabetic properties of these main species have been evidenced by experimental studies. Several antidiabetic compounds acting via different mechanisms have been identified, including momordicoside, karaviloside, cucurbitacin, charantin, and charantoside from M. charantia, cuminoside from S. cumini, S-allyl cysteine sulfoxide from A. sativum, limonoids from A. indica, alkaloids including vindoline, vindolidine, vindolicine and vindolinine from C. roseus, oleuropein and oleanolic acid from O. europaea, flavone C-glycosides such as vicenin-1, isoschaftoside, and schaftoside from T. foenum-graecum seeds, gymnemosides, gymnemagenin, and pregnane glycosides from G. sylvestre, chysalodin from A. vera, and quercetin from A. cepa.
Conclusion: This review is the first to provide a compiled list of traditional medicinal plants used worldwide against diabetes.
Export Options
About this article
Cite this article as:
Ethnomedicinal Plants for the Management of Diabetes Worldwide: A Systematic Review, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867328666210121123037
DOI https://dx.doi.org/10.2174/0929867328666210121123037 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics#
Current Alzheimer Research Potassium Channels and Uterine Vascular Adaptation to Pregnancy and Chronic Hypoxia
Current Vascular Pharmacology Role of Ischemia Modified Albumin Serum Levels as an Oxidative Stress Marker in Children with Diabetic Ketoacidosis
Combinatorial Chemistry & High Throughput Screening Novel Inflammatory Biomarkers in Cardiovascular Therapeutics
Current Medicinal Chemistry Stable Isotope Techniques to Develop and Monitor Nutrition Interventions
Current Nutrition & Food Science Assessment and Relevance of Carotid Intima-Media Thickness (C-IMT) in Primary and Secondary Cardiovascular Prevention
Current Pharmaceutical Design Global Account of Barriers and Facilitators of Physical Activity Among Patients with Diabetes Mellitus: A Narrative Review of the Literature
Current Diabetes Reviews A Contemporary Approach to Macular Edema Treatment in Retinal Vein Occlusion
Vascular Disease Prevention (Discontinued) Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
Current Vascular Pharmacology Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance
Current Pharmaceutical Design Pharmacogenomics of Cardiovascular Complications in Diabetes and Obesity
Recent Patents on Biotechnology Editorial [Hot Topic: Plasminogen Activator Inhibitor-1 (Guest Editor: Daniel A. Lawrence)]
Current Drug Targets Diabetes Therapy: Novel Patents Targeting the Glucose-Induced Insulin Secretion
Recent Patents on DNA & Gene Sequences The Impact of Type 2 Diabetes on Women’s Health and Well-being During Their Reproductive Years: A Mixed-methods Systematic Review
Current Diabetes Reviews Pharmacotherapy of Schizophrenia: The Past, Present and Future
Current Drug Therapy Pathophysiology and Therapeutics of Cardiovascular Disease in Metabolic Syndrome
Current Pharmaceutical Design Epigenetic Control of Hypertension by DNA Methylation: A Real Possibility
Current Pharmaceutical Design How Should Serum Uric Acid Concentrations be Interpreted in Patients with Hypertension?
Current Hypertension Reviews Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Activity Based Chemical Proteomics: Profiling Proteases as Drug Targets
Current Drug Discovery Technologies